Hel 13-5 trifluoroacetate salt structure
|
Common Name | Hel 13-5 trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 177942-21-1 | Molecular Weight | 2202.98 | |
Density | 1.1±0.1 g/cm3 | Boiling Point | 1967.1±65.0 °C at 760 mmHg | |
Molecular Formula | C113H204N24O19 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 1143.5±34.3 °C |
Use of Hel 13-5 trifluoroacetate saltHel 13-5 is a monomeric synthetic peptide based on the N-terminal segment of human SP-B. Hel 13-5 mainly is a-helical and consists of 13 hydrophobic and 5 hydrophilic amino acid residues. Hel 13-5 can be used in combination with phospholipids for developing pulmonary surfactant model systems[1][2]. |
Name | L-Lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-tryptophyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucine |
---|---|
Synonym | More Synonyms |
Description | Hel 13-5 is a monomeric synthetic peptide based on the N-terminal segment of human SP-B. Hel 13-5 mainly is a-helical and consists of 13 hydrophobic and 5 hydrophilic amino acid residues. Hel 13-5 can be used in combination with phospholipids for developing pulmonary surfactant model systems[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 1967.1±65.0 °C at 760 mmHg |
Molecular Formula | C113H204N24O19 |
Molecular Weight | 2202.98 |
Flash Point | 1143.5±34.3 °C |
Exact Mass | 2201.573486 |
LogP | 11.88 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.532 |
L-Leucine, L-lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-tryptophyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl- |
L-Lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-tryptophyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucine |
Hel 13-5 trifluoroacetate salt |